Diana Lueftner
AuthID: R-00J-NW8
1
TITLE: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3 (vol 15, pg 467, 2020) Full Text
AUTHORS: Diana Lueftner; Gary H Lyman; Joao Goncalves; Xavier Pivot; Minji Seo;
PUBLISHED: 2020, SOURCE: TARGETED ONCOLOGY
AUTHORS: Diana Lueftner; Gary H Lyman; Joao Goncalves; Xavier Pivot; Minji Seo;
PUBLISHED: 2020, SOURCE: TARGETED ONCOLOGY
INDEXED IN: 
WOS
WOS